ARCHIVES

GAO Report: Taxol CRADA “Successful,” But Not Great Financial Deal.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Final appropriations for NCI Still Probably $875 Million; US-USR Drug Book Available

July 1, 1977

DCBDC Bard Approves Expansion Of SPORE Program To GY Cancers; Okays Two other RFAs

December 4, 1992

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

In Brief: Ozer, Comis Join Allegheny Cancer Centers; Two Cooperative Groups Under Same Roof

March 21, 1997

Upton Prefers Keeping Bioassay Program In NCI

May 12, 1978

Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds

August 28, 2009